- Home
- PULM vs CLIR Comparison
PULM vs CLIR Comparison
Compare PULM & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- CLIR
- Stock Information
- Founded
- PULM 2003
- CLIR 2008
- Country
- PULM United States
- CLIR United States
- Employees
- PULM N/A
- CLIR N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- PULM Health Care
- CLIR Industrials
- Exchange
- PULM Nasdaq
- CLIR Nasdaq
- Market Cap
- PULM 20.5M
- CLIR 31.2M
- IPO Year
- PULM N/A
- CLIR 2012
- Fundamental
- Price
- PULM $5.57
- CLIR $0.57
- Analyst Decision
- PULM
- CLIR Strong Buy
- Analyst Count
- PULM 0
- CLIR 1
- Target Price
- PULM N/A
- CLIR $2.00
- AVG Volume (30 Days)
- PULM 10.9K
- CLIR 84.1K
- Earning Date
- PULM 08-12-2025
- CLIR 08-13-2025
- Dividend Yield
- PULM N/A
- CLIR N/A
- EPS Growth
- PULM N/A
- CLIR N/A
- EPS
- PULM N/A
- CLIR N/A
- Revenue
- PULM $1,921,000.00
- CLIR $2,895,000.00
- Revenue This Year
- PULM N/A
- CLIR $27.61
- Revenue Next Year
- PULM $134.88
- CLIR $116.19
- P/E Ratio
- PULM N/A
- CLIR N/A
- Revenue Growth
- PULM N/A
- CLIR 10.88
- 52 Week Low
- PULM $1.78
- CLIR $0.46
- 52 Week High
- PULM $10.40
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- PULM 36.25
- CLIR 47.77
- Support Level
- PULM $5.20
- CLIR $0.50
- Resistance Level
- PULM $6.15
- CLIR $0.63
- Average True Range (ATR)
- PULM 0.30
- CLIR 0.05
- MACD
- PULM -0.05
- CLIR 0.01
- Stochastic Oscillator
- PULM 22.70
- CLIR 48.19
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.